Protara Therapeutics
IPO- Headquarters
- New York, New York
- Employees
- 11–50
- Business Model
- B2B
- Website
- protaratx.com
- Type
- Public
About
Clinical-stage biopharmaceutical company developing transformative therapies for cancer and rare diseases.
Tech & App Stack
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingSimilar Companies

BridgeBio Pharma is a clinical-stage biopharmaceutical company developing therapies for genetic d...
Clinical-stage biopharmaceutical company developing FcRn inhibitor therapies for IgG-mediated aut...
Commercial-stage oncology company pioneering antibody drug conjugate therapies for cancer treatment.
Biopharmaceutical oncology company focused on discovery, development, and commercialization of ca...
Global clinical-stage biopharmaceutical company pursuing novel drug development platforms for rar...
Research-based development stage biopharmaceutical company that discovers and develops innovative...